| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $2.8M | -11.7% |
| SG&A Expense | $4.0M | +253.1% |
| Operating Income | -$6.8M | -56.9% |
| Net Income | -$8.9M | -14.0% |
| EPS (Basic) | -$0.88 | +39.7% |
| EPS (Diluted) | -$0.88 | +39.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Current Assets | $5.5M | +600.4% |
| Total Assets | $5.5M | +594.0% |
| Current Liabilities | $4.6M | -81.3% |
| Total Liabilities | $4.7M | -80.9% |
| Stockholders' Equity | -$5.2M | +78.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.3M | -142.2% |
| Investing Cash Flow | $1K | +0.0% |
| Financing Cash Flow | $12.8M | +344.7% |